Carlos Alban
CIK: 0001474632
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- May 15, 2026SOLV
Solventum Corp
Award(A)DirectRestricted Stock Units
3.3K shares- - Apr 30, 2026SOLV
Solventum Corp
Exercise(M)Direct3.4K shares- - Mar 27, 2026SOLV
Solventum Corp
Exercise(M)Direct2K shares- - Jul 1, 2025SWTX
SpringWorks Therapeutics, Inc.
Disposition(D)Direct28.9K shares- - May 14, 2025SWTX
SpringWorks Therapeutics, Inc.
Award(A)Direct10.1K shares- - May 13, 2025SOLV
Solventum Corp
Exercise(M)Direct3.6K shares- - Apr 30, 2025SOLV
Solventum Corp
Award(A)DirectRestricted Stock Units
3.4K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 15, 2026 |  SOLV Solventum Corp | Award(A) Restricted Stock Units | 3,300 | - | - | Direct |
| Apr 30, 2026 | SOLV Solventum Corp | Exercise(M) | 3,403 | - | $0 | Direct |
| Mar 27, 2026 | SOLV Solventum Corp | Exercise(M) | 1,980 | - | $0 | Direct |
| Jul 1, 2025 |  SWTX SpringWorks Therapeutics, Inc. | Disposition(D) | 28,861 | - | - | Direct |
| May 14, 2025 | SWTX SpringWorks Therapeutics, Inc. | Award(A) | 10,060 | - | - | Direct |
| May 13, 2025 | SOLV Solventum Corp | Exercise(M) | 3,564 | - | - | Direct |
| Apr 30, 2025 | SOLV Solventum Corp | Award(A) Restricted Stock Units | 3,403 | - | - | Direct |
1-7 of 7 transactions
About ALBAN CARLOS
ALBAN CARLOS (SEC CIK 0001474632) files insider reports with the SEC as Director of Solventum Corp (SOLV) and Director of SpringWorks Therapeutics, Inc. (SWTX).
Signal8 holds 7 ownership filings by ALBAN CARLOS, all Form 4s, filed between May 2, 2025 and May 18, 2026. Those filings report 7 transactions, from Apr 30, 2025 to May 15, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on ALBAN CARLOS's filings is in EAGAN, MN.
Recent filings by ALBAN CARLOS
- May 15, 2026: Grant or award of SOLV derivative securities (Form 4, code A).
- Apr 30, 2026: Option exercise of SOLV shares (Form 4, code M).
- Mar 27, 2026: Option exercise of SOLV shares (Form 4, code M).
- Jul 1, 2025: Disposition to issuer transaction of SWTX shares (Form 4, code D).
- May 14, 2025: Grant or award of SWTX shares (Form 4, code A).
Other insiders filing for Solventum Corp (SOLV)
- Hanson Bryan C, Chief Executive Officer
- Zieselman Neil Craig, SVP, Controller & CAO
- COX CARRIE SMITH, Director
- DeVore Susan D., Director
- Edwards Shirley Ann, Director
- EISENBERG GLENN A, Director